Recordati Posts 2021 Sales Rise As Market Recovers
Executive Summary
Italy's Recordati attributed a solid rise in OTC sales in 2021 to the recovery of the European market as the COVID-19 pandemic loosened its grip.
You may also be interested in...
Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
Recordati Launches Fortacin OTC In Germany Following EU-Wide Switch
Men in Germany can now purchase premature ejaculation treatment Fortacin without a prescription as a result of the EU-wide switch of the drug earlier this year.
People On The Move: Appointments At Alliance Pharma, Venture Life, Maxwellia
A round-up of the latest European consumer health industry appointments: Alliance Pharma names Jo LeCouilliard as chair; Venture Life hires Paul McGreevy as non-executive chair; and Maxwellia appoints Ian Adamson as a strategic advisor.